Lorus Therapeutics Inc. (Lorus) is a life sciences company focused on the discovery, research and development of anticancer therapies. The Company has worked to establish a diverse anticancer product pipeline, with products in various stages of development ranging from pre-clinical to an... more

GPC Biotech AG is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of anticancer drugs. Its lead product candidate is satraplatin, a platinum-based compound intended for use as a chemotherapy treatment. Unlike other platinum-based drugs,... more

Albany Molecular Research, Inc. provides scientific services, technologies and products. The Company's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing, and a separate, stand-alone research and development... more

Pharmacopeia, Inc. is a clinical development stage biopharmaceutical company dedicated to discovering and developing small molecule therapeutics to address medical needs. It has a portfolio of clinical and preclinical candidates under development internally or by partners, including eight... more

Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small molecule drugs that modulate ion channel targets. The Company has identified drug candidates that modulate ion channels. Its two most advanced programs are... more

Nastech is a clinical stage biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products based on our proprietary molecular biology-based drug delivery technologies and our proprietary ribonucleic acid interference technology. Nastech and... more

Isis Pharmaceuticals, Inc. (Isis) is a biopharmaceutical company engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. In addition to its antisense programs, the Company maintains technology leadership beyond its core areas of focus through... more

About Inpharmatica: (http://www.inpharmatica.com) Founded in 1998, Inpharmatica Ltd is a selective drug discovery company using predictive technologies to improve speed and productivity. Focusing on highly druggable targets, its unique proprietary platform, PharmaCarta (TM), is an... more

The Company was originally founded in 1987 with the objective of developing proprietary drug discovery technologies based on naturally occurring plants and organisms. Investment was made in selected target technologies, particularly in the cancer and cardiovascular therapeutic areas. As... more

Axys Pharmaceuticals, Inc. is an integrated small molecule drug discovery and development company. Axys has a broad pipeline of products for chronic therapeutic applications that are partnered with world-class pharmaceutical companies and a proprietary product portfolio in oncology. Axys... more

ChemCodes has developed a proprietary high throughput medicinal chemistry discovery and development platform that provides benefits of speed, diversity and quality which results in chemistry with better performance and small molecule development in a faster time period accomplished at a... more

ComGenex is a creative and dynamic company that is specialized in drug discovery technologies. Since 2001, ComGenex has focused on complex chemistry related discovery provision services. We have developed technologies to bridge the gap from genomics/proteomics to novel drug candidates.... more

MediChem Research, Inc. is a privately held discovery chemistry technology and services company that offers a broad range of research and development services to pharmaceutical and biotechnology companies involved in new drug discovery. The Company's efforts are focused on the efficient... more

Cyprotex provides high quality ADME and pharmacokinetic screening with our Cloe® Screen and Cloe® Select products. We also have extensive expertise in predictive modelling within our Cloe® Predict service. Our proprietary software, Cloe® PK, uses PB-PK modelling to integrate... more

NeoGenesis is a drug discovery company focused on using its proprietary technology platform to identify and develop a portfolio of small molecule-based drugs, both on behalf of its collaborators, who are among the leaders in the pharmaceutical and biotechnology industries, and for the... more

Cellomics, Inc. is automating drug discovery through a unique, cell-based assay platform that addresses the needs of Drug Discovery and Systems Biology groups by offering complete systems for High Content Screening. Cellomics' proprietary HCSinstruments, software, and assays are in use... more

Based in San Diego, CA., AVIVA Biosciences Corporation develops enabling drug discovery and development technologies by combining biochips with cell biology. Key application areas include electrophysiology research, ion channel drug screening and rare-cell isolation. Founded in 1999 the... more

Euroscreen is a privately held preclinical-stage biopharmaceutical company based in Brussels Belgium, focused on the discovery and development of small molecule drugs for unmet medical needs. Founded in 1994, as a spin-off of the "Université Libre de Bruxelles", initially developing and... more

BioSeek is a drug discovery company using its proprietary BioMAP cell-based human disease models to identify promising new therapeutic candidates. BioMAP technology incorporates primary human cells in systems engineered to capture the complexity of human disease biology in a highly... more

About Norak Biosciences, Inc. Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor technology to become a world leader in the discovery and development of drugs that regulate G protein-... more

In 2006, Trana developed the Trana HIV 101 Assay for the identification of new compounds for the treatment of HIV. Then in September of 2007, the company announced the follow-on development of the Trana HIV 201 high-throughput screening (HTS) Assay. The HTS assay was developed in... more

Over the last decade, Neugenesis has developed new technology for rapid and inexpensive discovery and production of high value biopharmaceutical drugs. The company has created proprietary platforms which provide: Better ways to produce complex drugs including multivalent vaccines... more

Ercole is developing a new class of drugs that modulate alternative splicing -- a natural gene regulatory mechanism. Ercole believes its technology is applicable to several major diseases, include cancer, inflammatory diseases and cardiovascular disorders.

Cresset provides a full hit finding and project support service to the biotechnology and pharmaceutical industry. We can handle all of your computational chemistry requirements, from the initial virtual screen through lead optimisation. We also provide a quality software support service... more

Cambridge Cell Networks (CCnet) is a computational systems biology company based in Cambridge, UK. Founded in 2002 as a spin-off from the University of Cambridge, CCnet has combined cutting-edge research in bioinformatics, proteomics and genomics, text-search and chemistry in order to... more

Vipergen is a biotech start-up company pioneering the successful implementation of small molecule DNA-display with its proprietary and cutting edge YoctoReactor® Technology. Vipergen aims to be the partner of choice in early-phase small molecule drug discovery efforts. Vipergen is... more

Multispan utilizes its proprietary technologies to develop the most comprehensive "one-stop shop" collection of high quality GPCR reagent products from genes, high-expression cell lines, membrane preparations, to monoclonal antibodies. Multispan also develops novel GPCR therapeutic... more

Otava provides the synthesis of compounds within a particular class of molecules selected by the customer. We have a chemical synthesis expertise in a wide range of drug discovery fields and can offer the production of compounds with exclusive or non-exclusive agreements (up to 100... more

Quantum Pharmaceuticals, a Moscow based company, was founded in 2002 as a privately held drug discovery company and raised its first round of venture financing in 2003. Since then we have added new alliances and collaborations to our portfolio and have made further advancements in our... more

Camitro Corporation is a privately held biopharmaceutical technology development company based in Menlo Park, California. The company is developing and will commercialize an innovative, fully integrated platform of predictive computational models and data that will enable drug discovery... more

Aurora, a subsidiary of Vertex Pharmaceuticals, is a leader in genomics, discovery services and discovery technologies through agreements with leading pharmaceutical and biotechnology companies. Aurora's sales growth reflects its commitment to providing outstanding technology solutions to... more

BSI Proteomics, Inc., Gaithersburg, MD, is a drug discovery technology company utilizing structural proteomics to create more effective drug candidates. BSI offers its proprietary Dynamically Controlled Crystallization SystemsTM (DCCSTM) to accelerate drug discovery. All DCCSTM systems... more

Cadus Corporation is engaged in the development and application of yeast-based and other drug discovery technologies. The Company has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all applications, licenses and drug discovery technologies of the... more

For resources and information on Software and Pharmaceuticals